You May Also Like

Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB
Cite
CITE Title : Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB Personal Author(s) : Millard, James;Rimmer, Stephanie;Nimmo, Camus;O’Donnell, Max; Published Date : 5 2023 Source : Emerg Infect Dis. 2023; 29(5):1081-1084 URL : https://stacks.cdc.gov/view/cdc/129110 Millard, James et al. (2023). Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB. 29(5). Millard, James et al. "Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB" 29, no. 5 (2023) Millard, James et al. "Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB" vol. 29, no. 5, 2023 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 544.89 KB]
Personal Author:
Millard, James ;
Rimmer, Stephanie
...
5 2023 | Emerg Infect Dis. 2023; 29(5):1081-1084
Description:
New classes of antitubercular drugs, diarylquinolines and nitroimidazoles, have been associated with improved outcomes in the treatment of drug-resist...
File Type:
[PDF - 544.89 KB]
File Type:
[PDF - 544.89 KB]

Six-Month Response to Delamanid Treatment in MDR TB Patients
Cite
CITE Title : Six-Month Response to Delamanid Treatment in MDR TB Patients Personal Author(s) : Hewison, Cathy;Ferlazzo, Gabriella;Avaliani, Zaza;Hayrapetyan, Armen;Jonckheere, Sylvie;Khaidarkhanova, Zarema;Mohr, Erika;Sinha, Animesh;Skrahina, Alena;Vambe, Debrah;Vasilyeva, Irina;Lachenal, Nathalie;Varaine, Francis; Published Date : Oct 17 2017 Source : Emerg Infect Dis. 23(10):1746-1748. URL : https://stacks.cdc.gov/view/cdc/48986 Hewison, Cathy et al. (2017). Six-Month Response to Delamanid Treatment in MDR TB Patients. 23(10). Hewison, Cathy et al. "Six-Month Response to Delamanid Treatment in MDR TB Patients" 23, no. 10 (2017) Hewison, Cathy et al. "Six-Month Response to Delamanid Treatment in MDR TB Patients" vol. 23, no. 10, 2017 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 336.63 KB]
Personal Author:
Hewison, Cathy ;
Ferlazzo, Gabriella
...
Oct 17 2017 | Emerg Infect Dis. 23(10):1746-1748.
Description:
Delamanid, recently available for the treatment of multidrug-resistant tuberculosis (MDR TB), has had limited use outside clinical trials. We present ...
File Type:
[PDF - 336.63 KB]
File Type:
[PDF - 336.63 KB]